home materials & merchandise hotline calendar press links   


I am  

I need  
ProgramsHIV/AIDS and HealthAbout GMHCPublic Policy and ActivismVolunteerEn EspanolDonate

  HIV/AIDS & Health > Treatment > Fact Sheets > Tuberculosis

Tuberculosis (TB)

 

What is TB?
TB (Tuberculosis) is a disease caused by bacteria (germ) that is spread through the air usually when a person who has the disease coughs, sneezes or breathes. Anyone can become infected with TB bacteria, but people with HIV/AIDS are at greater risk of getting sick with TB disease. Although TB can occur any place in the body, only TB disease in the lungs (pulmonary TB) or throat is contagious. TB can occur at any T-cell range above or below 200 T-cells.

What is the difference between TB infection and TB disease?
TB infection (latent TB) means that TB bacteria have gotten inside your body but are not active. People who are infected with TB usually have no symptoms and most do not become ill. They are not contagious.

TB disease (active TB) means that the TB bacteria have become active in your body and will make you sick. Only people with active TB disease can spread TB to others. TB disease can be prevented or cured, but if left untreated, it can be fatal.

What are the signs and symptoms of TB disease?
General symptoms of TB disease in the lungs or throat include fever, night sweats, weight loss, and fatigue. Pulmonary TB causes a persistent cough and sometimes bloody sputum (mucus). TB disease can occur with other infections, especially Pneumocystis carinii pneumonia (PCP) and Mycobacterium Avium Complex (MAC).

How is TB diagnosed?
To diagnose TB infection, your healthcare provider will give you a special skin test called a TST (Tuberculin Skin Test), which causes a bump to appear within several days if you are infected. A positive test means you have TB infection. If you have HIV the TST might not work. So to determine if you have active TB disease, a chest x-ray and sputum cultures need to be done. If you have a negative TST and are HIV positive, it is recommended that you receive a TST every six months to a year depending on your risk of coming in contact with the TB bacteria.

Can Active TB be prevented?
Yes. People with both HIV/AIDS and TB infection have an 8­10% risk per year of developing active TB disease. So Isoniazid, also called (INH) is used to prevent active TB. It is taken for 9 months. Rifadin® (rifampin) or Mycobutin® (rifabutin) along with (PZA) pyrazinamide can also be taken for 2 months. Your doctor should check you monthly for side effects. If you are infected and cannot take medicine to prevent TB disease, it is very important to have regular check-ups and contact your doctor as soon as you have signs of active TB disease. Also, remember to always cough or sneeze into tissues and ask others to do the same.

Can TB be treated?
Yes. TB disease can be treated and cured with medication. TB treatment starts with at least four drugs, but the number of drugs may be reduced after two months. People with HIV/AIDS have to take the drugs for a longer time than people without HIV. It is important to take all your medication until the doctor says that the TB has been cured. Skipping medication or stopping because you feel better might lead your TB to become contagious again. Your TB might become harder to treat and you might get sicker. Some drugs commonly used to treat TB include:

INH (Isoniazid)—side effects: liver problems, neuropathy (pain or tingling in your hands and feet), fever or rash. Drug tips: take with food to reduce stomach problems, take vitamin B6 to reduce neuropathy, do not drink alcohol (increases liver problems).

Rifadin® (Rifampin)—side effects: liver problems, fever, flu-like symptoms, can turn your body fluids orange (urine, feces, cum) and permanently stain soft contact lenses. Patients on methadone may need up to 50 percent increase to avoid withdrawal symptoms. Drug tips: do not drink alcohol, do not take with food (skipping medication may cause flu-like symptoms).

Additionally, rifampin should NOT be used with any of the currently available protease inhibitors. Rifampin reduces protease inhibitor levels by more than 90 percent while protease inhibitors increase rifampin levels.

Mycobutin® (Rifabutin)—side effects: irritation of the eye, skin rash, stomach pain and nausea; can also cause the same orange color changes to body fluids as rifampin.

Myambuto® (Ethambutol)—side effects: nausea, vomiting, eye problems and skin rashes

PZA (Pyrazinamide)—side effects: nausea, vomiting, rashes, liver problems, joint aches and pains. Drug tips: drink plenty of fluids daily

What is MDR-TB?
MDR-TB (multiple-drug resistant tuberculosis) is TB that is resistant to at least two of the standard drugs used to treat TB (INH and Rifampin). It means these drugs don’t work as well, or not at all, on your TB. Your TB can become resistant if you are not treated long enough, do not receive the right drugs or if you don’t take your medication properly.

You can also become directly infected with MDR-TB. MDR-TB can cause death within a few weeks in people with HIV/AIDS. So preventive treatment of suspected MDR infections is highly recommended. Treatment of MDR-TB disease requires the use of five or six drugs.

 

© 2003 Gay Men's Health Crisis





   HELP GMHC FIGHT AIDS!
Make a secure donation today.
Donation Information >

 

 



   Contact  |  Careers & Internships  |  Using This Site  |  Suggestion Box  |  Disclaimer



Gay Men's Health Crisis, The Tisch Building, 119 West 24 Street, New York, NY 10011, 212.367.1000
Press and media: Lynn Schulman, lynns@gmhc.org

CDC Disclaimer: This site contains HIV prevention messages that may not be appropriate for all audiences.

design by double k design